sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Medical Device Middle East and Africa Plasma Fractionation Market...

Marktprognose für Plasmafraktionierung im Nahen Osten und Afrika bis 2028 – Auswirkungen von COVID-19 und regionale Analyse nach Produkt (Immunglobulin, Albumin, Gerinnungsfaktorkonzentrate, Proteaseinhibitoren und andere Plasmaprodukte), Anwendung (Neurologie, Immunologie, Hämatologie, Intensivpflege, Pulmonologie). und andere Anwendungen) und Endbenutzer (Krankenhäuser und Kliniken, klinische Forschungslabore und akademische Institute)

TIPRE00026274 | Pages: 123 | Medical Device | Dec 2021 | Type: Regional | Status: Published

Markteinführung

Die Vereinigten Arabischen Emirate (VAE), Saudi-Arabien und Südafrika sind die 3 großen Länder in der MEA. Saudi-Arabien war im Jahr 2021 der größte Markt für Plasmafraktionierung in dieser Region. Der Markt für Plasmafraktionierung in der MEA wird im Prognosezeitraum voraussichtlich mit einer jährlichen Wachstumsrate von 5,2 % wachsen; Dieses Wachstum wird auf die steigende Prävalenz verschiedener Krankheiten und zunehmende Regierungsinitiativen in der Region zurückgeführt.

Wirtschaftliche Unsicherheiten und anhaltende Konflikte verschlimmern die Lage in der Region. Beispielsweise leiden Länder wie Syrien, Libyen und Jemen unter gewalttätigen Konflikten und können keine strengen Maßnahmen im Bereich der öffentlichen Gesundheit umsetzen. Der Iran befand sich aufgrund der US-Sanktionen in einer tiefen wirtschaftlichen Rezession. Die wichtigste Quelle der wirtschaftlichen Stabilisierung in den Ländern des Nahen Ostens ist außerdem die Ölförderung und der Export. Allerdings sorgt die COVID-19-Pandemie für Turbulenzen in den Volkswirtschaften des Nahen Ostens. Ein plötzlicher Rückgang der inländischen und externen Nachfrage nach Gütern und Produkten, insbesondere Rohöl, und ein Produktionsstopp aufgrund von Arbeitskräftemangel sind die wichtigsten in der Region beobachteten Auswirkungen. Die Ausbreitung von COVID-19 in der Region verursachte schwere Belastungen für das medizinische Fachpersonal. Herzchirurgen waren mit Herz-Notoperationen, der Behandlung von COVID-19-Patienten und der Umsetzung von Sicherheitsrichtlinien zur Verhinderung der Ausbreitung des Virus überlastet. Die schnelle Ausbreitung des Virus hatte Auswirkungen auf geplante Operationen. Daher wirkte sich der COVID-19-Ausbruch negativ auf das Wachstum des MEA-Plasmafraktionierungsmarktes aus.       

     
Marktüberblick und Dynamik

Die Plasmafraktionierung

Wichtige Marktsegmente

< Der Markt für MEA-Plasmafraktionierung ist in Produkt, Anwendung, Endbenutzer und Land unterteilt. Der Markt für MEA-Plasmafraktionierung wurde je nach Produkt in Immunglobulin, Albumin, Gerinnungsfaktorkonzentrate, Proteaseinhibitoren und andere unterteilt. Das Immunglobulin-Segment dürfte im Jahr 2021 den größten Marktanteil halten. Der Markt für MEA-Plasmafraktionierung ist je nach Anwendung in Neurologie, Immunologie, Hämatologie, Intensivpflege, Pulmonologie und andere unterteilt. Im Jahr 2021 dürfte das Segment Neurologie den größten Marktanteil halten. Der Markt für MEA-Plasmafraktionierung ist je nach Endverbraucher in Krankenhäuser und Kliniken, klinische Forschungslabore und akademische Institute unterteilt. Im Jahr 2021 dürfte das Segment Krankenhäuser und Kliniken den größten Marktanteil halten. Je nach Land ist der MEA-Plasmafraktionierungsmarkt in Saudi-Arabien, Südafrika, die Vereinigten Arabischen Emirate und den Rest der MEA unterteilt. Der Rest des MEA hatte im Jahr 2021 den größten Marktanteil.  

Wichtige Quellen und Unternehmen gelistet

Einige wichtige primäre und sekundäre Quellen, auf die bei der Erstellung dieses Berichts über den Plasmafraktionierungsmarkt in MEA verwiesen wird, sind unter anderem Unternehmenswebsites, Jahresberichte, Finanzberichte, nationale Regierungsdokumente und statistische Datenbanken Andere. Zu den wichtigsten im Bericht aufgeführten Unternehmen gehören Bharat Serums and Vaccines Limited (BSV); Bio Products Laboratory Ltd.; Biotest AG; CSL Limited; Grifols, SA; Kedrion SpA; Octapharma AG; und SK Plasma.            

Gründe dafür Kaufbericht

  • Um die Marktlandschaft der MEA-Plasmafraktionierung zu verstehen und die Marktsegmente zu identifizieren, die am stärksten vertreten sind wird wahrscheinlich eine starke Rendite garantieren.
  • Bleiben Sie der Konkurrenz einen Schritt voraus, indem Sie die sich ständig verändernde Wettbewerbslandschaft auf dem Markt für MEA-Plasmafraktionierung verstehen.
  • Planen Sie M&A- und Partnerschaftsgeschäfte im MEA-Plasmafraktionierungsmarkt effizient, indem Sie Marktsegmente mit den vielversprechendsten wahrscheinlichen Verkäufen identifizieren.
  • Hilft dabei, fundierte Geschäftsentscheidungen aus dem Blickwinkel zu treffen und umfassende Analyse der Marktleistung verschiedener Segmente des MEA-Plasmafraktionierungsmarktes.
  • Erhalten Sie eine Marktumsatzprognose für den Markt verschiedener Segmente von 2021 bis 2028 in der MEA-Region.

MEA Markt für Plasmafraktionierung Segmentierung

Markt für MEA-Plasmafraktionierung – Nach Produkt

  • Immunglobulin
    • Intravenöses Immunglobulin (IVIG)
    • Subkutanes Immunglobulin (SCIG). )
  • Albumin
  • Gerinnungsfaktorkonzentrate
  • Proteaseinhibitoren
  • Andere

Markt für MEA-Plasmafraktionierung - Nach Anwendung

  • Neurologie
  • Immunologie
  • Hämatologie
  • Intensivpflege
  • Pulmonologie
  • Andere

Markt für MEA-Plasmafraktionierung – bis Ende Benutzer

  • Krankenhäuser und Kliniken
  • Klinische Forschungslabore
  • Akademische Institute

Markt für MEA-Plasmafraktionierung – nach Land

  • Saudi-Arabien
  • Südafrika
  • Vereinigte Arabische Emirate
  • Rest der MEA

MEA-Plasmafraktionierungsmarkt – Unternehmensprofile

  • Bharat Serums and Vaccines Limited (BSV)
  • Bio Products Laboratory Ltd.
  • Biotest AG.
  • CSL Limited
  • Grifols, SA
  • Kedrion SpA
  • Octapharma AG
  • SK Plasma

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Plasma Fractionation Market – By Product

1.3.2        MEA Plasma Fractionation Market – By Application

1.3.3        MEA Plasma Fractionation Market – By End User

1.3.4        MEA Plasma Fractionation Market – By Country

2.           MEA Plasma Fractionation Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Plasma Fractionation Market – Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Plasma Fractionation Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Plasma Therapy Getting Popular

5.1.2        Significant Rise in Participation of the Players in Market Developments

5.2         Market Restraints

5.2.1        Various Non-Plasma Substitutes Available

5.3         Market Opportunities

5.3.1        Emerging Countries Showing Development Capability

5.4         Future Trends

5.4.1        Plasma Therapy in the Treatment of Novel Diseases

5.5         Impact Analysis

6.           Plasma Fractionation Market – MEA Analysis

6.1         MEA Plasma Fractionation Market Revenue Forecast and Analysis

7.           MEA Plasma Fractionation Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         MEA Plasma Fractionation Market, By Product 2021 & 2028 (%)

7.3         Immunoglobulin

7.3.1        Overview

7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.1          Intravenous Immunoglobulin (IVIG)

7.3.2.1.1          Overview

7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2          Subcutaneous Immunoglobulin (SCIG)

7.3.2.2.1          Overview

7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Albumin

7.4.1        Overview

7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Coagulation Factor Concentrates

7.5.1        Overview

7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Protease Inhibitors

7.6.1        Overview

7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Other Plasma Products

7.7.1        Overview

7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

8.           MEA Plasma Fractionation Market Revenue and Forecasts To 2028 – Application

8.1         Overview

8.2         MEA Plasma Fractionation Market Share by Application 2021 & 2028 (%)

8.3         Neurology

8.3.1        Overview

8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Immunology

8.4.1        Overview

8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Hematology

8.5.1        Overview

8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Critical Care

8.6.1        Overview

8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Pulmonology

8.7.1        Overview

8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Other Applications

8.8.1        Overview

8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.           MEA Plasma Fractionation Market Revenue and Forecasts To 2028 – End User

9.1         Overview

9.2         MEA Plasma Fractionation Market Share by End User 2021 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Clinical Research Laboratories

9.4.1        Overview

9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Academic Institutes

9.5.1        Overview

9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

10.        MEA Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     MEA Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1       UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1       Overview

10.1.1.1.2       UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.3       UAE: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.1    UAE: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.1.4       UAE: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.4.1    UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2       Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1       Overview

10.1.1.2.2       Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.3       Saudi Arabia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.1    Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.2.4       Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.5       Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3       South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1       Overview

10.1.1.3.2       South Africa Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.3       South Africa: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.1    South Africa: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.3.4       South Africa: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.4.1    South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4       Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1       Overview

10.1.1.4.2       Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.3       Rest of MEA: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.1    Rest of MEA: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.4.4       Rest of MEA: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.4.5       Rest of MEA: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on MEA Plasma Fractionation Market

11.1      MEA: Impact Assessment of COVID-19 Pandemic

12.        Plasma Fractionation Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Followed by Major Market Players (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic developments

12.4.1     Overview

13.        Company Profiles

13.1      Biotest AG.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Octapharma AG

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Kedrion S.p.A

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      CSL Limited

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Grifols, S.A.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bio Products Laboratory Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Bharat Serums and Vaccines Limited (BSV)

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      SK Plasma

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             UAE: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 2.             UAE: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             UAE: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Saudi Arabia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             South Africa Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 10.          South Africa: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          South Africa: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of MEA: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of MEA: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of MEA: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of MEA: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Organic Developments Done By Companies

Table 18.          Inorganic developments done by Companies

Table 19.          Glossary of Terms, MEA Plasma Fractionation Market

 


LIST OF FIGURES

Figure 1.           MEA Plasma Fractionation Market Segmentation

Figure 2.           MEA Plasma Fractionation Market Segmentation, By Country

Figure 3.           MEA Plasma Fractionation Market Overview

Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in MEA Plasma Fractionation Market

Figure 5.           Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6.           MEA PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to MEA Plasma Fractionation Market

Figure 8.           MEA Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9.           MEA Plasma Fractionation Market, by Product 2021 & 2028 (%)

Figure 10.        MEA Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        MEA Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        MEA Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        MEA Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        MEA Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        MEA Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 16.        MEA Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        MEA Plasma Fractionation Market Share by Application 2021 & 2028 (%)

Figure 18.        MEA Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19.        MEA Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20.        MEA Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21.        MEA Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 22.        MEA Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 23.        MEA Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 24.        MEA Plasma Fractionation Market Share by End User 2021 & 2028 (%)

Figure 25.        MEA Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 26.        MEA Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 27.        MEA Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 28.        MEA Plasma Fractionation Market Revenue Overview, by Country, 2021 (US$ Mn)

Figure 29.        MEA Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)

Figure 30.        UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.        South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34.        Impact of COVID-19 Pandemic in MEA Country Markets

Figure 35.        Growth Strategies Followed by Major Market Players (%)

  1. Bharat Serums and Vaccines Limited (BSV)
  2. Bio Products Laboratory Ltd.
  3. Biotest AG.
  4. CSL Limited
  5. Grifols, S.A.
  6. Kedrion S.p.A
  7. Octapharma AG
  8. SK Plasma
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA plasma fractionation market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the MEA plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S.. May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En.. May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription